Jacobs Levy Equity Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.44M | Buy |
495,291
+351,150
| +244% | +$4.57M | 0.03% | 381 |
|
|
2025
Q1 | $1.53M | Buy |
144,141
+24,583
| +21% | +$260K | 0.01% | 720 |
|
|
2024
Q4 | $2.03M | Buy |
119,558
+19,859
| +20% | +$337K | 0.01% | 587 |
|
|
2024
Q3 | $2.31M | Sell |
99,699
-637
| -0.6% | -$14.8K | 0.01% | 575 |
|
|
2024
Q2 | $2.44M | Buy |
100,336
+4,412
| +5% | +$107K | 0.01% | 571 |
|
|
2024
Q1 | $3.24M | Buy |
95,924
+50,470
| +111% | +$1.7M | 0.01% | 507 |
|
|
2023
Q4 | $1.43M | Buy |
45,454
+36,128
| +387% | +$1.14M | 0.01% | 660 |
|
|
2023
Q3 | $238K | Sell |
9,326
-7,912
| -46% | -$202K | ﹤0.01% | 906 |
|
|
2023
Q2 | $494K | Buy |
+17,238
| New | +$494K | ﹤0.01% | 826 |
|